From the Media

Home > From the Media

A Glimpse from the Media:

Thermo Fisher, Pluristem partner to scale up regenerative cell therapy manufacturing
Fierce Bio Tech, July 9, 2018
Clinical trial at Holy Name aims to save limbs and lives
NJTV news, June 26, 2018
Study shows placenta treatment effective against radiation sickness
The Times of Israel, June 26, 2018
US DoD to study PLX-R18 cell therapy to treat mustard gas injuries
Army technology, June 21, 2018
Israel’s Pluristem sees positive results from leg pain study
Reuters, June 12, 2018
Pluristem Breakthrough Brings Global Hope for Radiation Treatment
Bloomberg, May 22, 2018
FDA clears Pluristem radiation treatment for emergency use
Reuters, April 30, 2018
Uma vacina contra radiacoes nucleares
Sic noticias, March 24, 2018 (Portuguese)
JPost Smart cells that heal
The Jerusalem Post, February 14, 2018
North Korea nuclear fears boost demand for survivalist gear, services
The Washington Times, February 01, 2018
North Korea threats spur U.S. search for new radiation therapies
Reuters, January 31, 2018
JPost New hope for cancer patients
The Jerusalem Post, January 12, 2018
gen Stem Cell Manufacturing: It’s All about Scale
GEN news, January 1, 2018
FDA clears expanded access programme for Pluristem’s PLX-PAD cell treatment
EPM magazine, January 10, 2018
Pluristem Gets Accelerated Approval Pathways in Top 3 Healthcare Markets – U.S., Europe, Japan
Bio Informant, December 7, 2017
JPost ‘It’s time to invest in cell-based treatment for nuclear exposure’ 
The Jerusalem Post, December 7, 2017
Pluristem’s innovative technology, cell therapy products and a potentially answer for radiation exposure
i24News (French), November 19, 2017
Trending 2018: Pipeline Disrupters
Pharma Voice, November 2017
Pluristem Enters into Agreement with Tel Aviv Sourasky Medical Center to Conduct Phase I/II Trial in Steroid-Refractory Chronic GvHD
The New York Times, November 6, 2017
JPost Health Ministry approves pioneering placenta-cell therapy for blood disorders
Jerusalem Post, October 29, 2017
Die Welt (in German)
October 20, 2017
JPost Can the organ of life save lives?
Jerusalem Post, October 20, 2017
Pluristem Therapeutics (PSTI) Stock: Gaining On Orphan Drug Designation
CNA Finance, October 19, 2017
Cell Therapy for Chronic Disease
Drug Descovery & Development, October 18, 2017
BioSpace-logo New Published Data Highlights the Potential of Pluristem’s PLX Cells in Improving Cardiac Function in Diabetes
Bio Space, October 16, 2017
drug dev  

Pluristem: 3D Macrocarrier Bioreactor Technology Overcomes Limitations of 2D Microcarriers
Drug Development & Delivery, October issue 2017


U.S. FDA Grants Fast Track Designation to Pluristem’s PLX-PAD for the Treatment of CLI
Bio Informant, September 18, 2017


Pluristem Strengthens Its Position in Asia, Awarded Two New Patents in Hong Kong for Critical Limb Ischemia and Muscle Regeneration
Market Insider, September 13, 2017

logo-globes-en Stem cell co Pluristem awarded $8.7m EU grant
Globes, September 6, 2017
US military testing radiation exposure drug
CNN, September 5, 2017
gen U.S. DOD to Start New Trial with Pluristem’s PLX-R18 Cell Therapy Against ARS
GEN news, August 17, 2017
Surviving a Nuclear Attack
Real Clear Defense, August 4, 2017
energy voice Scientists find ‘cure’ for nuclear radiation exposure
Energy Voice, July 27, 2017
Seeking_Alpha_logo1 Pluristem’S Radiation Antidote Addresses $11 Billion Hematologic Indication In Human Trials
Seeking Alpha, July 23, 2017
marketwatch This new drug could help the U.S. survive a nuclear meltdown
Market Watch, July 18, 2017
JPost The Israeli company protecting against radiation catastrophe
Jerusalem Post, July 14, 2017
BioSpace-logo Pluristem Therapeutics (PSTI) Advances Its Multinational Phase III Critical Limb Ischemia Study
BioSpace, July 10, 2017
logo-globes-en The Health System Care in Israel-  A Reference to the OECD report (written in Hebrew)
Globes. July 3, 2017
fyi Critical Limb Ischemia- an unmet need
FYI News, June 2017
fyi Cell therapy – the next generation of biological therapeutic products
FYI News, June 2017
fyi Placental cell therapy
FYI News, June 2017
JPost  The Israeli company protecting against radiation catastrophe
Jerusalem Post, May 26, 2017
HSNW  Pocket-size biological solution to radioactive threats
Homeland Security news wire, May 15, 2017
HSNW  EXCLUSIVE: Are Governments Sufficiently Prepared for Nuclear Incidents?
Homeland Security Today, April 20, 2017
CNA-Finance-Logo1  Can Pluristem Therapeutics (PSTI) Corner The Acute Radiation Syndrome(ARS) Market?
CNA Finance, April 10, 2017
defense-news  US Tests Potential Israeli Cure for Victims of ‘Nuclear Terrorism’
Defense News, March 30, 2017
drug dev  CELL THERAPY – PLX-R18: Cell Therapy for Treatment of Acute Radiation Syndrome & Bone Marrow Failure Diseases
Drug Development, February 28, 2017
bio connection  Regenerative Medicine for Effective, Non-Invasive Treatment of Critical Limb Ischemia
The Bio Connection, February 15, 2017
gen  Pluristem, NYBC Win $900K to Test PLX-R18 Cells Alongside Cord Blood Transplants
GEN news, December 27, 2016
gen Pluristem, Sosei Set Up in Japan to Commercialize Cell Therapy for CLI
GEN news, December 20, 2016
Seeking_Alpha_logo1 Phase III Cell Therapy Company Pluristem Gets $8 Million Grant For Pivotal Trial In $12 Billion CLI Market
Seeking Alpha, August 21, 2016
orthopedic Pluristem: Trial of PLX-PAD Cells for Femoral Neck Fracture
Orthopedics this week, August 11, 2016